Article Details
Retrieved on: 2021-04-30 06:18:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca's COVID-19 vaccine delivered $275 million in first-quarter sales while shaving three cents per share from earnings, the drugmaker said ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here